dichlororibofuranosylbenzimidazole has been researched along with Cancer of Skin in 1 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hellung-Larsen, P | 1 |
| Jensen, EG | 1 |
| Frederiksen, S | 1 |
1 other study available for dichlororibofuranosylbenzimidazole and Cancer of Skin
| Article | Year |
|---|---|
Effect of 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole on the synthesis of low molecular weight, RNA components.
Topics: Animals; Cricetinae; Dichlororibofuranosylbenzimidazole; L Cells; Mice; Molecular Weight; Neoplasms, | 1981 |